-Blocker usage and colorectal cancer mortality: a nested case-control study in the UK Clinical Practice Research Datalink cohort

Improved survival outcomes with the incidental use of beta-blockers among patients with non-small-cell lung cancer treated with definitive radiation therapy

(2013) H. M. Wang et al.   ANNALS OF ONCOLOGY

Effect of Chronic Restraint Stress on Human Colorectal Carcinoma Growth in Mice

(2013) Qiang Lin et al.   PLoS One

Impact of beta blockers on epithelial ovarian cancer survival

(2012) Elena S. Diaz et al.   GYNECOLOGIC ONCOLOGY

New indication for therapeutic potential of an old well-known drug (propranolol) for multiple myeloma

(2012) Ilknur Kozanoglu et al.   JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY

Does β-adrenoceptor blocker therapy improve cancer survival? Findings from a population-based retrospective cohort study

(2011) Sunil M. Shah et al.   BRITISH JOURNAL OF CLINICAL PHARMACOLOGY

Involvement of α2- and β2-adrenoceptors on breast cancer cell proliferation and tumour growth regulation

(2011) C Pérez Piñero et al.   BRITISH JOURNAL OF PHARMACOLOGY

Beta Blockers and Breast Cancer Mortality: A Population- Based Study

(2011) Thomas I. Barron et al.   JOURNAL OF CLINICAL ONCOLOGY

Adaptation and validation of the Charlson Index for Read/OXMIS coded databases

(2010) Nada F Khan et al.   BMC Family Practice

β2-adrenergic antagonists suppress pancreatic cancer cell invasion by inhibiting CREB, NF-κB and AP-1

(2010) Dong Zhang et al.   CANCER BIOLOGY & THERAPY

Measuring cancer survival in populations: relative survival vs cancer-specific survival

(2010) D. Sarfati et al.   INTERNATIONAL JOURNAL OF EPIDEMIOLOGY

Norepinephrine upregulates VEGF, IL-8, and IL-6 expression in human melanoma tumor cell lines: Implications for stress-related enhancement of tumor progression

(2008) Eric V. Yang et al.   BRAIN BEHAVIOR AND IMMUNITY

Is norepinephrine an etiological factor in some types of cancer?

(2008) Paul J. Fitzgerald   INTERNATIONAL JOURNAL OF CANCER